Acta Neuropathologica Communications (Nov 2020)
Down syndrome cell adhesion molecule like-1 (DSCAML1) links the GABA system and seizure susceptibility
- Yoneko Hayase,
- Shigeru Amano,
- Koichi Hashizume,
- Takashi Tominaga,
- Hiroyuki Miyamoto,
- Yukie Kanno,
- Yukiko Ueno-Inoue,
- Takayoshi Inoue,
- Mayumi Yamada,
- Shigehiro Ogata,
- Shabeesh Balan,
- Ken Hayashi,
- Yoshiki Miura,
- Kentaro Tokudome,
- Yukihiro Ohno,
- Takuma Nishijo,
- Toshihiko Momiyama,
- Yuchio Yanagawa,
- Akiko Takizawa,
- Tomoji Mashimo,
- Tadao Serikawa,
- Akihiro Sekine,
- Eiji Nakagawa,
- Eri Takeshita,
- Takeo Yoshikawa,
- Chikako Waga,
- Ken Inoue,
- Yu-ichi Goto,
- Yoichi Nabeshima,
- Nobuo Ihara,
- Kazuhiro Yamakawa,
- Shinichiro Taya,
- Mikio Hoshino
Affiliations
- Yoneko Hayase
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Shigeru Amano
- Graduate School of Medicine Faculty of Health Science, Department of Laboratory Medicine, Kyoto University
- Koichi Hashizume
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Takashi Tominaga
- Laboratory for Neural Circuit System, Institute of Neuroscience, Tokushima Bunri University
- Hiroyuki Miyamoto
- International Research Center for Neurointelligence (IRCN), The University of Tokyo
- Yukie Kanno
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Yukiko Ueno-Inoue
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Takayoshi Inoue
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Mayumi Yamada
- Research Center for Dynamic Living Systems, Graduate School of Biostudies, Kyoto University
- Shigehiro Ogata
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Shabeesh Balan
- Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science
- Ken Hayashi
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Yoshiki Miura
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Kentaro Tokudome
- Department of Pharmacology, Osaka University of Pharmaceutical Sciences
- Yukihiro Ohno
- Department of Pharmacology, Osaka University of Pharmaceutical Sciences
- Takuma Nishijo
- Department of Pharmacology, Jikei University School of Medicine
- Toshihiko Momiyama
- Department of Pharmacology, Jikei University School of Medicine
- Yuchio Yanagawa
- Genetic and Behavioral Neuroscience, Gunma University Graduate School of Medicine
- Akiko Takizawa
- Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University
- Tomoji Mashimo
- Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University
- Tadao Serikawa
- Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University
- Akihiro Sekine
- Omics-Based Medicine, Center for Preventive Medical Science, Chiba University
- Eiji Nakagawa
- Department of Pediatric Neurology, National Center Hospital, NCNP
- Eri Takeshita
- Department of Pediatric Neurology, National Center Hospital, NCNP
- Takeo Yoshikawa
- Laboratory for Molecular Psychiatry, RIKEN Center for Brain Science
- Chikako Waga
- Department of Mental Retardation and Birth Defect Research, NCNP
- Ken Inoue
- Department of Mental Retardation and Birth Defect Research, NCNP
- Yu-ichi Goto
- Department of Mental Retardation and Birth Defect Research, NCNP
- Yoichi Nabeshima
- Foundation for Biomedical Research and Innovation
- Nobuo Ihara
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Kazuhiro Yamakawa
- Graduate School of Medical Science, Nagoya City University
- Shinichiro Taya
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- Mikio Hoshino
- Department of Biochemistry and Cellular Biology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)
- DOI
- https://doi.org/10.1186/s40478-020-01082-6
- Journal volume & issue
-
Vol. 8,
no. 1
pp. 1 – 17
Abstract
Abstract The Ihara epileptic rat (IER) is a mutant model with limbic-like seizures whose pathology and causative gene remain elusive. In this report, via linkage analysis, we identified Down syndrome cell adhesion molecule-like 1(Dscaml1) as the responsible gene for IER. A single base mutation in Dscaml1 causes abnormal splicing, leading to lack of DSCAML1. IERs have enhanced seizure susceptibility and accelerated kindling establishment. Furthermore, GABAergic neurons are severely reduced in the entorhinal cortex (ECx) of these animals. Voltage-sensitive dye imaging that directly presents the excitation status of brain slices revealed abnormally persistent excitability in IER ECx. This suggests that reduced GABAergic neurons may cause weak sustained entorhinal cortex activations, leading to natural kindling via the perforant path that could cause dentate gyrus hypertrophy and epileptogenesis. Furthermore, we identified a single nucleotide substitution in a human epilepsy that would result in one amino acid change in DSCAML1 (A2105T mutation). The mutant DSCAML1A2105T protein is not presented on the cell surface, losing its homophilic cell adhesion ability. We generated knock-in mice (Dscaml1 A2105T ) carrying the corresponding mutation and observed reduced GABAergic neurons in the ECx as well as spike-and-wave electrocorticogram. We conclude that DSCAML1 is required for GABAergic neuron placement in the ECx and suppression of seizure susceptibility in rodents. Our findings suggest that mutations in DSCAML1 may affect seizure susceptibility in humans.
Keywords